Biofermin Pharmaceutical. (4517.TSE) Q2 2013 Earnings

26JulExpected
Q4 2011
Q1 2012
Q1 2013
Q2 2013
29.79
38.58
47.38
56.17

Details

Expected EPS
N/A
Actual EPS
56.1706
Surprise EPS
56.17
Surprise Percent
+∞%

Description

Biofermin Pharmaceutical. (4517.TSE) has reported earnings of 56.1706 per share for Q2 2013.

0 Comments

Share your thoughts